Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews

Background: The European Academy of Allergy and Clinical Immunology (EAACI) is developing Guidelines on Allergen Immunotherapy (AIT) for Allergic Rhinoconjunctivitis (ARC). To inform the development of recommendations, we sought to critically assess the systematic review evidence on the effectivenes...

Full description

Saved in:
Bibliographic Details
Main Authors: Nurmatov, Ulugbek (Author) , Pfaar, Oliver (Author)
Format: Article (Journal)
Language:English
Published: 08 August 2017
In: Clinical and translational allergy
Year: 2017, Volume: 7
ISSN:2045-7022
DOI:10.1186/s13601-017-0159-6
Online Access:Verlag, Volltext: http://dx.doi.org/10.1186/s13601-017-0159-6
Verlag, Volltext: https://doi.org/10.1186/s13601-017-0159-6
Get full text
Author Notes:Ulugbek Nurmatov, Sangeeta Dhami, Stefania Arasi, Graham Roberts, Oliver Pfaar, Antonella Muraro, Ignacio J. Ansotegui, Moises Calderon, Cemal Cingi, Stephen Durham, Roy Gerth van Wijk, Susanne Halken, Eckard Hamelmann, Peter Hellings, Lars Jacobsen, Edward Knol, Desiree Larenas-Linnemann, Sandra Y. Lin, Vivian Maggina, Hanneke Oude-Elberink, Giovanni Pajno, Ruby Panwankar, Elideanna Pastorello, Constantinos Pitsios, Giuseppina Rotiroti, Frans Timmermans, Olympia Tsilochristou, Eva-Maria Varga, Jamie Wilkinson, Andrew Williams, Margitta Worm, Luo Zhang and Aziz Sheikh

MARC

LEADER 00000caa a2200000 c 4500
001 1577489926
003 DE-627
005 20220814190536.0
007 cr uuu---uuuuu
008 180711s2017 xx |||||o 00| ||eng c
024 7 |a 10.1186/s13601-017-0159-6  |2 doi 
035 |a (DE-627)1577489926 
035 |a (DE-576)507489926 
035 |a (DE-599)BSZ507489926 
035 |a (OCoLC)1341013353 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Nurmatov, Ulugbek  |e VerfasserIn  |0 (DE-588)1162546980  |0 (DE-627)1026680530  |0 (DE-576)50748987X  |4 aut 
245 1 0 |a Allergen immunotherapy for allergic rhinoconjunctivitis  |b a systematic overview of systematic reviews  |c Ulugbek Nurmatov, Sangeeta Dhami, Stefania Arasi, Graham Roberts, Oliver Pfaar, Antonella Muraro, Ignacio J. Ansotegui, Moises Calderon, Cemal Cingi, Stephen Durham, Roy Gerth van Wijk, Susanne Halken, Eckard Hamelmann, Peter Hellings, Lars Jacobsen, Edward Knol, Desiree Larenas-Linnemann, Sandra Y. Lin, Vivian Maggina, Hanneke Oude-Elberink, Giovanni Pajno, Ruby Panwankar, Elideanna Pastorello, Constantinos Pitsios, Giuseppina Rotiroti, Frans Timmermans, Olympia Tsilochristou, Eva-Maria Varga, Jamie Wilkinson, Andrew Williams, Margitta Worm, Luo Zhang and Aziz Sheikh 
264 1 |c 08 August 2017 
300 |a 16 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 11.07.2018 
520 |a Background: The European Academy of Allergy and Clinical Immunology (EAACI) is developing Guidelines on Allergen Immunotherapy (AIT) for Allergic Rhinoconjunctivitis (ARC). To inform the development of recommendations, we sought to critically assess the systematic review evidence on the effectiveness, safety and cost-effectiveness of AIT for ARC. Methods: We undertook a systematic overview, which involved searching nine international biomedical databases from inception to October 31, 2015. Studies were independently screened by two reviewers against pre-defined eligibility criteria and critically appraised using the Critical Appraisal Skills Programme (CASP) Systematic Review Checklist for systematic reviews. Data were descriptively synthesized. Results: Our searches yielded a total of 5932 potentially eligible studies, from which 17 systematic reviews met our inclusion criteria. Eight of these were judged to be of high, five moderate and three low quality. These reviews suggested that, in carefully selected patients, subcutaneous (SCIT) and sublingual (SLIT) immunotherapy resulted in significant reductions in symptom scores and medication requirements. Serious adverse outcomes were rare for both SCIT and SLIT. Two systematic reviews reported some evidence of potential cost savings associated with use of SCIT and SLIT. Conclusions: We found moderate-to-strong evidence that SCIT and SLIT can, in appropriately selected patients, reduce symptoms and medication requirements in patients with ARC with reassuring safety data. This evidence does however need to be interpreted with caution, particularly given the heterogeneity in the populations, allergens and protocols studied. There is a lack of data on the relative effectiveness, cost-effectiveness and safety of SCIT and SLIT. We are now systematically reviewing all the primary studies, including recent evidence that has not been incorporated into the published systematic reviews. 
650 4 |a Allergen immunotherapy 
650 4 |a Allergic rhinitis 
650 4 |a Allergic rhinoconjuctivitis 
650 4 |a Allergy 
650 4 |a Hay fever 
650 4 |a Rhinitis 
700 1 |a Pfaar, Oliver  |d 1972-  |e VerfasserIn  |0 (DE-588)12385900X  |0 (DE-627)706454049  |0 (DE-576)293913099  |4 aut 
773 0 8 |i Enthalten in  |t Clinical and translational allergy  |d Hoboken, NJ : Wiley, 2011  |g 7(2017) Artikel-Nummer 24, 16 Seiten  |h Online-Ressource  |w (DE-627)669883573  |w (DE-600)2630865-4  |w (DE-576)351552952  |x 2045-7022  |7 nnas  |a Allergen immunotherapy for allergic rhinoconjunctivitis a systematic overview of systematic reviews 
773 1 8 |g volume:7  |g year:2017  |g extent:16  |a Allergen immunotherapy for allergic rhinoconjunctivitis a systematic overview of systematic reviews 
856 4 0 |u http://dx.doi.org/10.1186/s13601-017-0159-6  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://doi.org/10.1186/s13601-017-0159-6  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180711 
993 |a Article 
994 |a 2017 
998 |g 12385900X  |a Pfaar, Oliver  |m 12385900X:Pfaar, Oliver  |d 60000  |d 62100  |e 60000PP12385900X  |e 62100PP12385900X  |k 0/60000/  |k 1/60000/62100/  |p 5 
999 |a KXP-PPN1577489926  |e 3017288323 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 11.07.2018"],"relHost":[{"title":[{"title":"Clinical and translational allergy","title_sort":"Clinical and translational allergy","subtitle":"CTA"}],"origin":[{"publisherPlace":"Hoboken, NJ ; London","dateIssuedKey":"2011","dateIssuedDisp":"2011-","publisher":"Wiley ; BioMed Central"}],"name":{"displayForm":["European Academy of Allergy and Clinical Immunology (EAACI)"]},"note":["Gesehen am 06.04.2021"],"id":{"eki":["669883573"],"zdb":["2630865-4"],"doi":["10.1002/(ISSN)2045-7022"],"issn":["2045-7022"]},"part":{"year":"2017","extent":"16","text":"7(2017) Artikel-Nummer 24, 16 Seiten","volume":"7"},"physDesc":[{"extent":"Online-Ressource"}],"titleAlt":[{"title":"CTA"}],"language":["eng"],"disp":"Allergen immunotherapy for allergic rhinoconjunctivitis a systematic overview of systematic reviewsClinical and translational allergy","recId":"669883573","pubHistory":["1.2011 -"],"type":{"bibl":"periodical","media":"Online-Ressource"}}],"physDesc":[{"extent":"16 S."}],"id":{"doi":["10.1186/s13601-017-0159-6"],"eki":["1577489926"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title_sort":"Allergen immunotherapy for allergic rhinoconjunctivitis","subtitle":"a systematic overview of systematic reviews","title":"Allergen immunotherapy for allergic rhinoconjunctivitis"}],"language":["eng"],"person":[{"family":"Nurmatov","given":"Ulugbek","display":"Nurmatov, Ulugbek","role":"aut"},{"family":"Pfaar","display":"Pfaar, Oliver","given":"Oliver","role":"aut"}],"origin":[{"dateIssuedDisp":"08 August 2017","dateIssuedKey":"2017"}],"name":{"displayForm":["Ulugbek Nurmatov, Sangeeta Dhami, Stefania Arasi, Graham Roberts, Oliver Pfaar, Antonella Muraro, Ignacio J. Ansotegui, Moises Calderon, Cemal Cingi, Stephen Durham, Roy Gerth van Wijk, Susanne Halken, Eckard Hamelmann, Peter Hellings, Lars Jacobsen, Edward Knol, Desiree Larenas-Linnemann, Sandra Y. Lin, Vivian Maggina, Hanneke Oude-Elberink, Giovanni Pajno, Ruby Panwankar, Elideanna Pastorello, Constantinos Pitsios, Giuseppina Rotiroti, Frans Timmermans, Olympia Tsilochristou, Eva-Maria Varga, Jamie Wilkinson, Andrew Williams, Margitta Worm, Luo Zhang and Aziz Sheikh"]},"recId":"1577489926"} 
SRT |a NURMATOVULALLERGENIM0820